Nicholson K - Search Results

1

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M. Stephenson I, et al. Among authors: nicholson k. Clin Infect Dis. 2009 Feb 15;48(4):389-96. doi: 10.1086/596311. Clin Infect Dis. 2009. PMID: 19133796 Free article.

2

Influenza.

Nicholson KG, Wood JM, Zambon M. Nicholson KG, et al. Lancet. 2003 Nov 22;362(9397):1733-45. doi: 10.1016/S0140-6736(03)14854-4. Lancet. 2003. PMID: 14643124 Free PMC article. Review.

3

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

Stephenson I, Bugarini R, Nicholson KG, Podda A, Wood JM, Zambon MC, Katz JM. Stephenson I, et al. J Infect Dis. 2005 Apr 15;191(8):1210-5. doi: 10.1086/428948. Epub 2005 Mar 14. J Infect Dis. 2005. PMID: 15776364 Clinical Trial.

4

Influenza: vaccination and treatment.

Stephenson I, Nicholson KG. Stephenson I, et al. Among authors: nicholson kg. Eur Respir J. 2001 Jun;17(6):1282-93. doi: 10.1183/09031936.01.00084301. Eur Respir J. 2001. PMID: 11491177 Free article. Review.

5

Influenza-related hospitalizations among young children in Leicestershire.

Nicholson KG, McNally T, Silverman M, Simons P, Zambon MC. Nicholson KG, et al. Pediatr Infect Dis J. 2003 Oct;22(10 Suppl):S228-30. doi: 10.1097/01.inf.0000092193.91306.2f. Pediatr Infect Dis J. 2003. PMID: 14551481

6

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.

Stephenson I, Nicholson KG, Glück R, Mischler R, Newman RW, Palache AM, Verlander NQ, Warburton F, Wood JM, Zambon MC. Stephenson I, et al. Lancet. 2003 Dec 13;362(9400):1959-66. doi: 10.1016/S0140-6736(03)15014-3. Lancet. 2003. PMID: 14683655 Clinical Trial.

7

Confronting the avian influenza threat: vaccine development for a potential pandemic.

Stephenson I, Nicholson KG, Wood JM, Zambon MC, Katz JM. Stephenson I, et al. Lancet Infect Dis. 2004 Aug;4(8):499-509. doi: 10.1016/S1473-3099(04)01105-3. Lancet Infect Dis. 2004. PMID: 15288823 Free PMC article. Review.

8

Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children.

Nicholson KG, McNally T, Silverman M, Simons P, Stockton JD, Zambon MC. Nicholson KG, et al. Vaccine. 2006 Jan 9;24(1):102-8. doi: 10.1016/j.vaccine.2005.02.004. Epub 2005 Feb 25. Vaccine. 2006. PMID: 16310899

9

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.

Stephenson I, Zambon MC, Rudin A, Colegate A, Podda A, Bugarini R, Del Giudice G, Minutello A, Bonnington S, Holmgren J, Mills KH, Nicholson KG. Stephenson I, et al. J Virol. 2006 May;80(10):4962-70. doi: 10.1128/JVI.80.10.4962-4970.2006. J Virol. 2006. PMID: 16641287 Free PMC article. Clinical Trial.

10

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I. Clark TW, et al. Among authors: nicholson kg. N Engl J Med. 2009 Dec 17;361(25):2424-35. doi: 10.1056/NEJMoa0907650. Epub 2009 Sep 10. N Engl J Med. 2009. PMID: 19745215 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters